Peritransplantation Use of Ruxolitinib in Myelofibrosis.

Ibrahim, Uroosa; Petrone, Giulia Eva Maria; Mascarenhas, John; Keyzner, Alla

Ibrahim, Uroosa; Petrone, Giulia Eva Maria; Mascarenhas, John; Keyzner, Alla.

Afiliación

Ibrahim U; Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: uroosa.ibrahim@mssm.edu.
Petrone GEM; Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Mascarenhas J; Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Keyzner A; Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

Biol Blood Marrow Transplant ; 26(12): 2177-2180, 2020 12.

Article en En | MEDLINE | ID: mdl-32818555

Asunto(s)

Trasplante de Células Madre Hematopoyéticas; Mielofibrosis Primaria; Humanos; Nitrilos; Mielofibrosis Primaria/tratamiento farmacológico; Inhibidores de Proteínas Quinasas/uso terapéutico; Pirazoles/uso terapéutico; Pirimidinas

Palabras clave

Allogeneic transplant; HSCT; Myelofibrosis; Ruxolitinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria Límite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google